Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia
Descriptive Study Regarding the Ambulant Screening Protocol for COVID-19 in Times of High SARS CoV-2 Prevalence
1 other identifier
observational
528
1 country
1
Brief Summary
Descriptive prospective study to investigate the prevalence of COVID 19 during ambulant screening
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2020
CompletedFirst Posted
Study publicly available on registry
April 6, 2020
CompletedStudy Start
First participant enrolled
April 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2020
CompletedJanuary 6, 2021
January 1, 2021
8 months
April 2, 2020
January 5, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
Prevalence of symptoms
Prevalence of fever, cough, anorexia, fatigue, diarrhea, vomiting, dyspnee, sore throat and sputum
at the ambulant screening
Prevalence of positive Sars CoV-2 PCR
Prevalence of positive COVID 19 tests in patients planned for surgery, treatment or investigation in the hospital
at the ambulant screening
Prevalence of positive radiological findings
Prevalence of positive radiological findings in CT scans of the lungs of planned for surgery, treatment or investigation in the hospital
at the ambulant screening
Secondary Outcomes (3)
Prediction of symptoms
2 weeks after surgery or treatment
Prediction of symptoms
2 weeks after surgery or treatment
Prediction of symptoms
2 weeks after surgery or treatment
Interventions
Questionnaire
Eligibility Criteria
All adult patients scheduled for a (semi) urgent surgery, hematological or oncological treatment or elektrophysiciological investigations in the Jessa hospital and seen at the pre-operative consultation will be asked to participate and to fullfill the questionnaire
You may qualify if:
- All adult patients \> 18 years scheduled for a (semi) urgent surgery, hematological or oncological treatment or elektrophysiciological investigations in the Jessa hospital
You may not qualify if:
- Patients \< 18 years
- Adult patients who are unable the give informed consent
- Language barrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jessa Hospitallead
Study Sites (1)
Jessa hospital
Hasselt, 3500, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr
Study Record Dates
First Submitted
April 2, 2020
First Posted
April 6, 2020
Study Start
April 17, 2020
Primary Completion
December 20, 2020
Study Completion
December 20, 2020
Last Updated
January 6, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share